Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 97

This age-related deterioration affects both innate and adaptive immunity, compromising immune function and leading to chronic inflammation that accelerates aging. Immunosenescence is characterized by alterations in immune cell populations and impaired functionality, resulting in increased susceptibility to infections, diminished vaccine efficacy, and higher prevalence of age-related diseases. Chronic low-grade inflammation further exacerbates these issues, contributing to a decline in overall health and resilience. This review delves into the characteristics of immunosenescence and examines the various intrinsic and extrinsic factors contributing to immune aging and how the hallmarks of aging and cell fates can play a crucial role in this process. Additionally, it discusses the impact of sex, age, social determinants, and gut microbiota health on immune aging, illustrating the complex interplay of these factors in altering immune function. Furthermore, the concept of immune resilience is explored, focusing on the metrics for assessing immune health and identifying strategies to enhance immune function. These strategies include lifestyle interventions such as diet, regular physical activity, stress management, and the use of gerotherapeutics and other approaches. Understanding and mitigating the effects of immunosenescence are crucial for developing interventions that support robust immune responses in aged individuals.

The immune system plays a crucial role in protecting our bodies from harmful pathogens. It is divided into two segments: innate immunity and adaptive immunity. The innate immune system acts as an immediate but non-specific first responder to defend against pathogens, composed of phagocytic and natural killer cells. Besides innate immune cells, another important component of the innate system includes physical barriers like skin and mucous membranes. Meanwhile, adaptive immunity is more specialized and requires time to mount a high-affinity and specific response, relying on anticipatory receptors that recognize pathogen-specific antigens. The adaptive immune response is centered around B and T lymphocytes, which are produced in the bone marrow and thymus, respectively (Farber, 2020; Lam et al., 2024). With age, the ability of our immune system to mount productive and timely responses to pathogens diminishes.

Read more | >

Dr. Anirban Maitra is a Professor of Pathology and Translational Molecular Pathology at MD Anderson Cancer Center. His research focuses on the early detection and treatment of pancreatic cancer.

Originally studying pediatric pathology, Dr. Maitra’s career trajectory changed upon attending a seminar on pancreatic cancer, which motivated him to address knowledge gaps in the disease’s biology. He wanted to explore the molecular and clinical aspects of the disease for the sake of improving patient prognosis. “This is a disease where there’s an opportunity to make a huge difference,” said Dr. Maitra.

Later, Dr. Maitra’s lab developed a pancreatic cancer liquid biopsy method, which is a non-invasive blood test that detects the presence of tumors. “There’s still a long way to go, but now we know what to look for and who to look in,” said Dr. Maitra regarding the future direction of pancreatic cancer detection.

Read more | >

Scientists at Washington State University and Lawrence Berkeley National Laboratory have discovered a way to make ions move more than ten times faster in mixed organic ion-electronic conductors. These conductors combine the advantages of the ion signaling used by many biological systems, including the human body, with the electron signaling used by computers.

The new development, detailed in the journal Advanced Materials, speeds up ion movement in these conductors by using molecules that attract and concentrate ions into a separate nanochannel creating a type of tiny “ion superhighway.”

Read more | >

Hospitals around the country are conserving critical intravenous fluid supplies to cope with a shortage that may last months. Some hospital administrators say they are changing how they think about IV fluid hydration altogether.

Hurricane Helene, which hit North Carolina in September, wrecked a Baxter International facility that produces 60% of the IV fluids used in the U.S., according to the American Hospital Association.

The company was forced to stop production and is rationing its products. In an update posted Nov. 7, Baxter said its North Cove facility had resumed producing some IV fluids. In an email to KFF Health News, the company wrote that customers will be able to order normal quantities of “certain IV solutions products” by the end of the year, but there is no timeline for when the North Cove facility will be back to prehurricane production levels.

Read more | >

But according to recent research into patient attitudes on AI, providers should be thinking carefully about how they deploy those tools if they want to preserve patient trust.

Earlier this fall, Mark Polyak, president of analytics at IPSOS, and Dr. Lukasz Kowalczyk, a physician at Peak Gastroenterology Associates, spoke on a panel discussion at the HIMSS AI in Healthcare Forum that explored patients’ perspectives and attitudes about healthcare AI. Above all, they’re seeking healthcare interactions and experiences that are transparent and personalized, experts on the panel said.

Read more | >

Some sequences in the genome cause genes to be switched on or off. Until now, each of these gene switches, or so-called enhancers, was thought to have its own place on the DNA. Different enhancers are therefore separated from each other, even if they control the same gene, and switch it on in different parts of the body.

A recent study from the University of Bonn and the LMU Munich challenges this idea. The findings are also important because gene switches are thought to play a central role in evolution. The study has been published in the journal Science Advances.

The blueprint of plant and animal forms is encoded in their DNA. But only a small part of the genome—about two percent in mammals—contains genes, the instructions for making proteins. The rest largely controls when and where these genes are active: how many of their transcripts are produced, and thus how many proteins are made from these transcripts.

Read more | >

The delivery of nanomedicines using gas bubbles has shown itself to be a unique way of transporting cytotoxins to the lungs of cancer patients. The method enables precise and focused treatments, and the local action of the drugs also prevents a range of side-effects.

Read more | >

Researchers at Karolinska Institutet and Karolinska University Hospital have developed a microscopy method that enables detailed three-dimensional (3D) RNA analysis at cellular resolution in whole intact mouse brains. The new method, called TRISCO, has the potential to transform our understanding of brain function, both in normal conditions and in disease, according to a new study published in Science.

Despite great advances in RNA analysis, linking RNA data to its spatial context has long been a challenge, especially in intact 3D tissue volumes. The TRISCO method now makes it possible to perform three-dimensional RNA imaging of whole mouse brains without the need to slice the brain into thin sections, which was previously necessary.

“This method is a powerful tool that can drive forward. With TRISCO, we can study the complex anatomical structure of the brain in a way that was previously not possible,” says Per Uhlén, professor at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, and the study’s last author.

Read more | >

Numbers tell a story. From your credit score to your age, metrics predict a variety of outcomes, whether it’s your likelihood to get a loan or your risk for heart disease. Now, Stanford Medicine researchers have described another telling metric — one that can predict mortality. It’s called sleep age.

Sleep age is a projected age that correlates to one’s health based on their quality of sleep. So for instance, if you analyze the sleep characteristics of dozens of 55-year-olds and average them out, you’ll have an idea of what sleep looks like at that age. For instance, someone who’s 55 and sleeps soundly through the night with good quality REM cycles could, theoretically, might have a sleep age of 45.

Read more | >